Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_assertion type Assertion NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_head.
- NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_provenance.
- NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_assertion evidence source_evidence_literature NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_provenance.
- NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_assertion SIO_000772 22334453 NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_provenance.
- NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_assertion wasDerivedFrom befree-2016 NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_provenance.
- NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_assertion wasGeneratedBy ECO_0000203 NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_provenance.